MICHAELA BRESKI: Open Payments
NPI 1528407939 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 15 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $0 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Madrigal Pharmaceuticals | 3 | $67 |
| Ardelyx, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: REZDIFFRA, MAVYRET, IBSRELA, LINZESS, TREMFYA, VOWST, XIFAXAN, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
